Clinical Research Directory
Browse clinical research sites, groups, and studies.
Low-intensity Versus Medium-intensity Continuous Kidney Replacement Therapy for Critically Ill Patients
Sponsor: Jikei University School of Medicine
Summary
This clinical trial aims to investigate whether the low treatment intensity (12 mL/kg/hr, low-dose hemodialysis/filtration) or the medium treatment intensity (25 mL/kg/hr, standard-dose hemodialysis/filtration) is more effective and safer for continuous renal replacement therapy in critically ill patients.
Official title: Low-Intensity Versus Medium-Intensity Continuous Kidney Replacement Therapy for Critically Ill Patients (LIMIT): a Multicenter Randomized Clinical Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
400
Start Date
2023-10-30
Completion Date
2026-09
Last Updated
2024-10-15
Healthy Volunteers
No
Interventions
Dialysate fluid, Filtration replacement fluid
Dose of continuous hemodialysis and/or hemofiltration
Locations (9)
Sendai Medical Center
Sendai, Miyagi, Japan
Osaka Medical and Pharmaceutical University Hospital
Takatsuki, Osaka, Japan
University of Fukui Hospital
Fukui, Japan
Tsuchiura Kyodo General Hospital
Ibaraki, Japan
Osaka University Hospital
Osaka, Japan
Jichi Medical University Hospital
Tochigi, Japan
Jikei University Hospital
Tokyo, Japan
Keio University Hospital
Tokyo, Japan
Wakayama Medical University Hospital
Wakayama, Japan